Unprecedented biobanking effort to combat COVID-19
In April 2nd, at the peak of the COVID-19 surge, the Mount Sinai Health System (MSHS) announced the launch of an unprecedented biobanking effort to combat COVID-19. The goal was to rapidly collect blood samples from hundreds of COVID-19 patients admitted to MSHS to...
The Design Lab – Exploring Innovations in Clinical Trial Design
In February of 2020, Turner S. Baker, Ph.D. Candidate and Project Manager at Sinai BioDesign and Dr. Christopher Kellner, Assistant Professor and Director of the Intracerebral Hemorrhage Program were chosen from a highly competitive pool of applicants to participate...
ISMMS CTSA, ConduITS Evaluation and Continuous Improvement (ECI) Core
The mission of the ISMMS CTSA, ConduITS, is to streamline and centralize the infrastructure needed to accelerate translational research across an ever expanding research enterprise; foster team science responsive to emerging theories, technologies, and data science...
Mount Sinai and Rensselaer Polytechnic Institute (RPI) collaborated on two COVID critical needs projects with funding from the CTSA
Early in the COVID-19 pandemic, interdisciplinary teams at Mount Sinai and Rensselaer Polytechnic Institute (RPI) collaborated on two COVID critical needs projects with funding from the CTSA. The teams of scientists at Mount Sinai and RPI with complementary expertise...
“Insights to Inspire” Supporting early-career trainees and scholars with Dr. Janice Gabrilove
Registration for the July 29th kick-off webinar for the Insights to Inspire (I2I) 2020 series is now open. Insights to Inspire (I2I) 2020 highlights those CTSA hubs who have made improvements in their Careers in Clinical Translational Research metric. The first...
COVID Related ConduITS/ORS Response
The ConduITS Institute for Translational Sciences at the Icahn School of Medicine at Mount Sinai (ISMMS) is the Clinical & Translational Science Award (CTSA) Program for the Mount Sinai Health System established in 2009 with funding from the National Institutes...
Preliminary Case Series Leads to New Questions About the Disease Progression of COVID-19 in Patients with Blood Clots in the Lung
A small, preliminary case series led by physicians at the Icahn School of Medicine at Mount Sinai found that five severely ill patients with the SARS-CoV-2 virus responded to the blood-clot-busting drug tPA when it was introduced as a life-saving measure. This...
ISMMS Researchers Share Experience using the TIN sIRB
The TIN (The Trial Innovation Network) is an innovative national collaboration between a network of CTSA hubs. The TIN addresses critical roadblocks in clinical research by accelerating the translation of novel interventions into life-saving therapies. The ConduITS...
CureQuest Videogame: A Case Study in Team Science
Creating a sense of wonderment about the challenging process of drug discovery is no easy task. “CureQuest” rises to the challenge in videogame form, A mobile episodic game application primarily aimed at iOS and Android devices, drawing players into a magical world where they must develop a cure for a mysterious new ailment.